SCHEMBL19798775

SCHEMBL19798775

CCN1c2c(C)cc(C)cc2Sc2cc(C(F)(F)F)cc(C)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 3/20 0.38
MAPT P10636 3/20 0.34
ALOX12 P18054 1/20 0.34
PTPN5 P54829 1/20 0.33
GABRB3 P28472 5/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
NPC1 O15118 2/20 0.31
MAPK1 P28482 2/20 0.31
RAB9A P51151 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NSD2 O96028 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19808671 0.94 PTPN5 (0.36) RAPGEF4MAPTPTPN5GABRB3GABRA2
SCHEMBL19798776 0.88 MAPT (0.34) MAPTALOX12NPC1MAPK1RAB9A
SCHEMBL19798778 0.71 MAPT (0.34) MAPTLMNATP53
SCHEMBL17356867 0.71 MAPK1 (0.42) MAPTNPC1MAPK1RAB9AKDM4E
SCHEMBL17353592 0.67 TP53 (0.47) MAPTALOX12PTPN5NPC1MAPK1
SCHEMBL29865250 0.67 TP53 (0.47) MAPTALOX12PTPN5NPC1MAPK1
SCHEMBL22600834 0.64 MAPT (0.32) MAPTALOX12KDM4EALDH1A1
SCHEMBL19798774 0.64 KDM1A (0.37) MAPTALOX12NPC1RAB9AKDM4E
SCHEMBL17356871 0.63 MEN1 (0.40) MAPTNPC1MAPK1RAB9AKDM4E
SCHEMBL107119 0.62 RAPGEF4 (0.56) RAPGEF4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF PFAS, SLC6A9, PEX3 RAPGEF4 964/4885MAPT 4553/4885ALOX12 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.